Case 2: Assessing Severity and Rapid Progression in Alopecia Areata

Dr. Ungar reads Case 2, a 29-year-old woman whose patchy scalp loss progressed from 21 percent to 36 percent over three months. She has no eyebrow, eyelash, or nail involvement and no autoimmune or atopic history. Topical corticosteroids and rosemary oil have helped little, and she has begun avoiding social events and covering her head at work.

He finds the case very typical. Progression over about three months is common, but the most important feature is anxiety that interferes with her work, productivity, and social life. Dr. Ungar addresses the view that this is just hair and she can wear a covering, saying the effect on her life is huge. She also fears further progression, which can indeed happen.

By SALT alone, 36 percent loss would be moderate. Using the alopecia areata scale, the significant progression and psychosocial burden upgrade her to severe disease. Dr. Ungar calls this a clear-cut severe case in which psychosocial impact plays a core role.

Addressing the burden ideally involves a multidisciplinary approach that includes therapists, social support, and support groups. Still, one of the most powerful interventions is helping her regrow her hair, which requires medical therapy. Patients who regrow hair often feel like themselves again, almost like new people, although some fear of relapse persists. That benefit is a driving factor in escalating to systemic therapy. Staying on treatment also lowers the likelihood of worsening and of later flares. The case concludes with the decision to start a JAK inhibitor given the rate of progression and psychosocial burden.

The next episode in this series, "Alopecia Areata Patient-Reported Outcomes: Defining Treatment Success and Monitoring Response," features Dr. Ungar reviewing patient satisfaction data and timelines for judging response.